Cargando…

Clinical implications of early caudate dysfunction in Parkinson’s disease

OBJECTIVE: Although not typical of Parkinson’s disease (PD), caudate dopaminergic dysfunction can occur in early stages of the disease. However, its frequency and longitudinal implications in large cohorts of recently diagnosed patients remain to be established. We investigated the occurrence of cau...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pasquini, Jacopo, Durcan, Rory, Wiblin, Louise, Gersel Stokholm, Morten, Rochester, Lynn, Brooks, David James, Burn, David, Pavese, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Movement Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817982/ https://www.ncbi.nlm.nih.gov/pubmed/31079063 http://dx.doi.org/10.1136/jnnp-2018-320157

Ejemplares similares

Stability of mild cognitive impairment in newly diagnosed Parkinson's disease
por: Lawson, Rachael A, et al.
Publicado: (2017)

Features of GBA-associated Parkinson’s disease at presentation in the UK Tracking Parkinson’s study
por: Malek, Naveed, et al.
Publicado: (2018)

Visual dysfunction is a better predictor than retinal thickness for dementia in Parkinson’s disease
por: Hannaway, Naomi, et al.
Publicado: (2023)

Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts
por: Lawton, Michael, et al.
Publicado: (2022)

Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
por: Swallow, Diane M A, et al.
Publicado: (2016)

Multicentre, randomised controlled trial of PDSAFE, a physiotherapist-delivered fall prevention programme for people with Parkinson’s
por: Chivers Seymour, Kim, et al.
Publicado: (2019)

Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
por: Lawton, Michael, et al.
Publicado: (2018)

Visual hallucinations in the differential diagnosis of parkinsonism
por: Bertram, Kelly, et al.
Publicado: (2012)

Brain iron deposition is linked with cognitive severity in Parkinson’s disease
por: Thomas, George Edward Calver, et al.
Publicado: (2020)

Using ‘dead or dependent’ as an outcome measure in clinical trials in Parkinson's disease
por: McGhee, David, et al.
Publicado: (2015)

The prediagnostic phase of Parkinson's disease
por: Noyce, Alastair John, et al.
Publicado: (2016)

The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease
por: Barker, Roger A, et al.
Publicado: (2013)

How I treat Parkinson's disease
por: Barbosa, Egberto Reis, et al.
Publicado: (2022)

Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study
por: Moreau, Caroline, et al.
Publicado: (2013)

Combining biomarkers for prognostic modelling of Parkinson’s disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022)

Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson’s disease
por: Stoker, Thomas B, et al.
Publicado: (2020)

Cortical thinning is associated with disease stages and dementia in Parkinson's disease
por: Zarei, Mojtaba, et al.
Publicado: (2013)

Pisa syndrome in Parkinson's disease: a mobile or fixed deformity?
por: Doherty, Karen M, et al.
Publicado: (2013)

Bilateral adaptive deep brain stimulation is effective in Parkinson's disease
por: Little, Simon, et al.
Publicado: (2016)

Validation of new diagnostic criteria for fatigue in patients with Parkinson disease
por: Siciliano, Mattia, et al.
Publicado: (2022)

Systematic review of data‐driven cognitive subtypes in Parkinson disease
por: Pourzinal, Dana, et al.
Publicado: (2022)

Bone health in Parkinson's disease: a systematic review and meta-analysis
por: Torsney, Kelli M, et al.
Publicado: (2014)

Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges
por: Xiao, Bin, et al.
Publicado: (2016)

Parkinson’s disease determinants, prediction and gene–environment interactions in the UK Biobank
por: Jacobs, Benjamin Meir, et al.
Publicado: (2020)

Comparative whole transcriptome analysis of Parkinson’s disease focusing on the efficacy of zonisamide
por: Naito, Tatsuhiko, et al.
Publicado: (2022)

Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms
por: Mazzucchi, Sonia, et al.
Publicado: (2022)

Deep brain stimulation in Parkinson’s disease: state of the art and future perspectives
por: França, Carina, et al.
Publicado: (2022)

PREDICT-PD: Identifying risk of Parkinson's disease in the community: methods and baseline results
por: Noyce, Alastair J, et al.
Publicado: (2014)

Efficacy of intensive multidisciplinary rehabilitation in Parkinson’s disease: a randomised controlled study
por: Ferrazzoli, Davide, et al.
Publicado: (2018)

Long‐term independence and quality of life after subthalamic stimulation in Parkinson disease
por: Castrioto, Anna, et al.
Publicado: (2022)

Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease
por: Sauerbier, Anna, et al.
Publicado: (2021)

Magnetic resonance and dopamine transporter imaging for the diagnosis of Parkinson´s disease: a narrative review
por: Otani, Rafael Tomio Vicentini, et al.
Publicado: (2022)

Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis
por: Moisan, Frédéric, et al.
Publicado: (2016)

Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohort
por: Simuni, Tanya, et al.
Publicado: (2018)

A composite clinical motor score as a comprehensive and sensitive outcome measure for Parkinson’s disease
por: Lo, Christine, et al.
Publicado: (2022)

Prevalence and genotype–phenotype correlations of GBA‐related Parkinson disease in a large Chinese cohort
por: Ren, Jingru, et al.
Publicado: (2022)

From trials to clinical practice: Temporal trends in the coverage of specialized allied health services for Parkinson's disease
por: Bloem, Bastiaan R., et al.
Publicado: (2020)

The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism
por: Klebe, Stephan, et al.
Publicado: (2013)

Late onset depression: dopaminergic deficit and clinical features of prodromal Parkinson’s disease: a cross-sectional study
por: Kazmi, Hiba, et al.
Publicado: (2021)

Prognostic predictors relevant to end-of-life palliative care in Parkinson’s disease and related disorders: a systematic review
por: Akbar, Umer, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hv69g4isj16na0rlu26s0qno2t